ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹5.43 Cr | ₹13 Cr | ₹11 Cr | ₹14 Cr | ₹29 Cr |
What is the latest Contingent Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Contingent Liabilities |
---|---|
Mar2023 | ₹5.43 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹11 Cr |
Mar2020 | ₹14 Cr |
Mar2019 | ₹29 Cr |
How is Contingent Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹5.43 Cr | -58.48 | |
Mar2022 | ₹13 Cr | 15.98 | |
Mar2021 | ₹11 Cr | -16.73 | |
Mar2020 | ₹14 Cr | -54.06 | |
Mar2019 | ₹29 Cr | - |
Compare Contingent Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹4,421.7 Cr | 2.5% | 13.8% | 53.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | 2.5% |
13.8% |
53.7% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses